BTC Capital Management Inc. Sells 220 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

BTC Capital Management Inc. trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.2% in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 2,182 shares of the medical equipment provider’s stock after selling 220 shares during the quarter. BTC Capital Management Inc.’s holdings in Intuitive Surgical were worth $817,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ISRG. Norges Bank bought a new stake in Intuitive Surgical in the 4th quarter worth about $915,360,000. Morgan Stanley increased its holdings in Intuitive Surgical by 29.9% in the 4th quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock worth $1,556,706,000 after buying an additional 1,351,002 shares in the last quarter. Alliancebernstein L.P. grew its stake in shares of Intuitive Surgical by 8.0% during the 4th quarter. Alliancebernstein L.P. now owns 7,373,473 shares of the medical equipment provider’s stock valued at $1,956,551,000 after purchasing an additional 544,463 shares during the period. BlackRock Inc. grew its stake in shares of Intuitive Surgical by 1.7% during the 1st quarter. BlackRock Inc. now owns 28,918,406 shares of the medical equipment provider’s stock valued at $7,387,785,000 after purchasing an additional 470,624 shares during the period. Finally, Clearbridge Investments LLC grew its stake in shares of Intuitive Surgical by 23.1% during the 1st quarter. Clearbridge Investments LLC now owns 2,428,635 shares of the medical equipment provider’s stock valued at $732,671,000 after purchasing an additional 455,461 shares during the period. 82.91% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $305.68, for a total value of $152,840.00. Following the sale, the director now owns 702 shares in the company, valued at $214,587.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 2,535 shares of the stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $323.26, for a total value of $819,464.10. Following the sale, the executive vice president now owns 7,259 shares in the company, valued at $2,346,544.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 500 shares of the stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $305.68, for a total value of $152,840.00. Following the completion of the sale, the director now owns 702 shares in the company, valued at approximately $214,587.36. The disclosure for this sale can be found here. Insiders have sold a total of 60,309 shares of company stock worth $19,649,321 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $298.17 on Tuesday. The company has a market cap of $104.78 billion, a P/E ratio of 74.73, a P/E/G ratio of 4.15 and a beta of 1.30. The business’s 50 day moving average price is $314.56 and its 200-day moving average price is $298.07. Intuitive Surgical, Inc. has a fifty-two week low of $180.07 and a fifty-two week high of $358.07.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Intuitive Surgical had a return on equity of 12.41% and a net margin of 21.38%. The company’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.85 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 4.53 EPS for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent research reports. Barclays boosted their price target on Intuitive Surgical from $314.00 to $385.00 and gave the company an “overweight” rating in a research note on Monday, July 24th. Morgan Stanley boosted their price target on Intuitive Surgical from $310.00 to $330.00 and gave the company an “equal weight” rating in a research note on Monday, July 24th. StockNews.com initiated coverage on Intuitive Surgical in a research note on Thursday, August 17th. They set a “buy” rating for the company. TheStreet upgraded Intuitive Surgical from a “c+” rating to a “b” rating in a research note on Monday, July 24th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $360.00 price objective on shares of Intuitive Surgical in a research report on Thursday, August 17th. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $343.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.